Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8TH3

Structure of AT118-H Nanobody Antagonist in Complex with the Angiotensin II Type I Receptor

8TH3 の概要
エントリーDOI10.2210/pdb8th3/pdb
EMDBエントリー41248 41249
分子名称AT118-H nanobody, Type-1 angiotensin II receptor, Soluble cytochrome b562 complex, BAG2 Anti-BRIL Fab Heavy Chain, BAG2 Anti-BRIL Fab Light Chain, ... (4 entities in total)
機能のキーワードg protein-coupled receptor, nanobody, signaling protein-immune system complex, signaling protein/immune system
由来する生物種Camelidae
詳細
タンパク質・核酸の鎖数4
化学式量合計179783.30
構造登録者
Skiba, M.A.,Kruse, A.C. (登録日: 2023-07-13, 公開日: 2024-05-22, 最終更新日: 2024-12-04)
主引用文献Skiba, M.A.,Sterling, S.M.,Rawson, S.,Zhang, S.,Xu, H.,Jiang, H.,Nemeth, G.R.,Gilman, M.S.A.,Hurley, J.D.,Shen, P.,Staus, D.P.,Kim, J.,McMahon, C.,Lehtinen, M.K.,Rockman, H.A.,Barth, P.,Wingler, L.M.,Kruse, A.C.
Antibodies expand the scope of angiotensin receptor pharmacology.
Nat.Chem.Biol., 20:1577-1585, 2024
Cited by
PubMed Abstract: G-protein-coupled receptors (GPCRs) are key regulators of human physiology and are the targets of many small-molecule research compounds and therapeutic drugs. While most of these ligands bind to their target GPCR with high affinity, selectivity is often limited at the receptor, tissue and cellular levels. Antibodies have the potential to address these limitations but their properties as GPCR ligands remain poorly characterized. Here, using protein engineering, pharmacological assays and structural studies, we develop maternally selective heavy-chain-only antibody ('nanobody') antagonists against the angiotensin II type I receptor and uncover the unusual molecular basis of their receptor antagonism. We further show that our nanobodies can simultaneously bind to angiotensin II type I receptor with specific small-molecule antagonists and demonstrate that ligand selectivity can be readily tuned. Our work illustrates that antibody fragments can exhibit rich and evolvable pharmacology, attesting to their potential as next-generation GPCR modulators.
PubMed: 38744986
DOI: 10.1038/s41589-024-01620-6
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (3 Å)
構造検証レポート
Validation report summary of 8th3
検証レポート(詳細版)ダウンロードをダウンロード

250059

件を2026-03-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon